SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/16/19 Cannex Capital Holdings Inc. 40FR12G 138:29M Newsfile Corp/FA |
Document/Exhibit Description Pages Size 1: 40FR12G Registration of Securities of a Canadian Issuer HTML 112K 2: EX-99.1 Miscellaneous Exhibit -- exhibit99-1 HTML 53K 11: EX-99.10 Miscellaneous Exhibit -- exhibit99-10 HTML 30K 101: EX-99.100 Miscellaneous Exhibit -- exhibit99-100 HTML 49K 102: EX-99.101 Miscellaneous Exhibit -- exhibit99-101 HTML 872K 103: EX-99.102 Miscellaneous Exhibit -- exhibit99-102 HTML 78K 104: EX-99.103 Miscellaneous Exhibit -- exhibit99-103 HTML 70K 105: EX-99.104 Miscellaneous Exhibit -- exhibit99-104 HTML 35K 106: EX-99.105 Miscellaneous Exhibit -- exhibit99-105 HTML 2.88M 107: EX-99.106 Miscellaneous Exhibit -- exhibit99-106 HTML 34K 108: EX-99.107 Miscellaneous Exhibit -- exhibit99-107 HTML 33K 109: EX-99.108 Miscellaneous Exhibit -- exhibit99-108 HTML 39K 110: EX-99.109 Miscellaneous Exhibit -- exhibit99-109 HTML 290K 12: EX-99.11 Miscellaneous Exhibit -- exhibit99-11 HTML 156K 111: EX-99.110 Miscellaneous Exhibit -- exhibit99-110 HTML 133K 112: EX-99.111 Miscellaneous Exhibit -- exhibit99-111 HTML 33K 113: EX-99.112 Miscellaneous Exhibit -- exhibit99-112 HTML 33K 114: EX-99.113 Miscellaneous Exhibit -- exhibit99-113 HTML 42K 115: EX-99.114 Miscellaneous Exhibit -- exhibit99-114 HTML 32K 116: EX-99.115 Miscellaneous Exhibit -- exhibit99-115 HTML 39K 117: EX-99.116 Miscellaneous Exhibit -- exhibit99-116 HTML 34K 118: EX-99.117 Miscellaneous Exhibit -- exhibit99-117 HTML 37K 119: EX-99.118 Miscellaneous Exhibit -- exhibit99-118 HTML 455K 120: EX-99.119 Miscellaneous Exhibit -- exhibit99-119 HTML 133K 13: EX-99.12 Miscellaneous Exhibit -- exhibit99-12 HTML 30K 121: EX-99.120 Miscellaneous Exhibit -- exhibit99-120 HTML 33K 122: EX-99.121 Miscellaneous Exhibit -- exhibit99-121 HTML 33K 123: EX-99.122 Miscellaneous Exhibit -- exhibit99-122 HTML 41K 124: EX-99.123 Miscellaneous Exhibit -- exhibit99-123 HTML 36K 125: EX-99.124 Miscellaneous Exhibit -- exhibit99-124 HTML 491K 126: EX-99.125 Miscellaneous Exhibit -- exhibit99-125 HTML 140K 127: EX-99.126 Miscellaneous Exhibit -- exhibit99-126 HTML 33K 128: EX-99.127 Miscellaneous Exhibit -- exhibit99-127 HTML 33K 129: EX-99.128 Miscellaneous Exhibit -- exhibit99-128 HTML 30K 130: EX-99.129 Miscellaneous Exhibit -- exhibit99-129 HTML 492K 14: EX-99.13 Miscellaneous Exhibit -- exhibit99-13 HTML 32K 131: EX-99.130 Miscellaneous Exhibit -- exhibit99-130 HTML 143K 132: EX-99.131 Miscellaneous Exhibit -- exhibit99-131 HTML 32K 133: EX-99.132 Miscellaneous Exhibit -- exhibit99-132 HTML 32K 134: EX-99.133 Miscellaneous Exhibit -- exhibit99-133 HTML 30K 135: EX-99.134 Miscellaneous Exhibit -- exhibit99-134 HTML 69K 136: EX-99.135 Miscellaneous Exhibit -- exhibit99-135 HTML 31K 137: EX-99.136 Miscellaneous Exhibit -- exhibit99-136 HTML 29K 138: EX-99.137 Miscellaneous Exhibit -- exhibit99-137 HTML 30K 15: EX-99.14 Miscellaneous Exhibit -- exhibit99-14 HTML 32K 16: EX-99.15 Miscellaneous Exhibit -- exhibit99-15 HTML 32K 17: EX-99.16 Miscellaneous Exhibit -- exhibit99-16 HTML 33K 18: EX-99.17 Miscellaneous Exhibit -- exhibit99-17 HTML 34K 19: EX-99.18 Miscellaneous Exhibit -- exhibit99-18 HTML 42K 20: EX-99.19 Miscellaneous Exhibit -- exhibit99-19 HTML 33K 3: EX-99.2 Miscellaneous Exhibit -- exhibit99-2 HTML 31K 21: EX-99.20 Miscellaneous Exhibit -- exhibit99-20 HTML 45K 22: EX-99.21 Miscellaneous Exhibit -- exhibit99-21 HTML 145K 23: EX-99.22 Miscellaneous Exhibit -- exhibit99-22 HTML 77K 24: EX-99.23 Miscellaneous Exhibit -- exhibit99-23 HTML 32K 25: EX-99.24 Miscellaneous Exhibit -- exhibit99-24 HTML 32K 26: EX-99.25 Miscellaneous Exhibit -- exhibit99-25 HTML 35K 27: EX-99.26 Miscellaneous Exhibit -- exhibit99-26 HTML 28K 28: EX-99.27 Miscellaneous Exhibit -- exhibit99-27 HTML 38K 29: EX-99.28 Miscellaneous Exhibit -- exhibit99-28 HTML 34K 30: EX-99.29 Miscellaneous Exhibit -- exhibit99-29 HTML 782K 4: EX-99.3 Miscellaneous Exhibit -- exhibit99-3 HTML 28K 31: EX-99.30 Miscellaneous Exhibit -- exhibit99-30 HTML 30K 32: EX-99.31 Miscellaneous Exhibit -- exhibit99-31 HTML 49K 33: EX-99.32 Miscellaneous Exhibit -- exhibit99-32 HTML 31K 34: EX-99.33 Miscellaneous Exhibit -- exhibit99-33 HTML 51K 35: EX-99.34 Miscellaneous Exhibit -- exhibit99-34 HTML 35K 36: EX-99.35 Miscellaneous Exhibit -- exhibit99-35 HTML 36K 37: EX-99.36 Miscellaneous Exhibit -- exhibit99-36 HTML 42K 38: EX-99.37 Miscellaneous Exhibit -- exhibit99-37 HTML 36K 39: EX-99.38 Miscellaneous Exhibit -- exhibit99-38 HTML 38K 40: EX-99.39 Miscellaneous Exhibit -- exhibit99-39 HTML 35K 5: EX-99.4 Miscellaneous Exhibit -- exhibit99-4 HTML 30K 41: EX-99.40 Miscellaneous Exhibit -- exhibit99-40 HTML 35K 42: EX-99.41 Miscellaneous Exhibit -- exhibit99-41 HTML 35K 43: EX-99.42 Miscellaneous Exhibit -- exhibit99-42 HTML 35K 44: EX-99.43 Miscellaneous Exhibit -- exhibit99-43 HTML 36K 45: EX-99.44 Miscellaneous Exhibit -- exhibit99-44 HTML 31K 46: EX-99.45 Miscellaneous Exhibit -- exhibit99-45 HTML 28K 47: EX-99.46 Miscellaneous Exhibit -- exhibit99-46 HTML 454K 48: EX-99.47 Miscellaneous Exhibit -- exhibit99-47 HTML 29K 49: EX-99.48 Miscellaneous Exhibit -- exhibit99-48 HTML 114K 50: EX-99.49 Miscellaneous Exhibit -- exhibit99-49 HTML 33K 6: EX-99.5 Miscellaneous Exhibit -- exhibit99-5 HTML 1.56M 51: EX-99.50 Miscellaneous Exhibit -- exhibit99-50 HTML 33K 52: EX-99.51 Miscellaneous Exhibit -- exhibit99-51 HTML 49K 53: EX-99.52 Miscellaneous Exhibit -- exhibit99-52 HTML 31K 54: EX-99.53 Miscellaneous Exhibit -- exhibit99-53 HTML 44K 55: EX-99.54 Miscellaneous Exhibit -- exhibit99-54 HTML 31K 56: EX-99.55 Miscellaneous Exhibit -- exhibit99-55 HTML 297K 57: EX-99.56 Miscellaneous Exhibit -- exhibit99-56 HTML 101K 58: EX-99.57 Miscellaneous Exhibit -- exhibit99-57 HTML 33K 59: EX-99.58 Miscellaneous Exhibit -- exhibit99-58 HTML 33K 60: EX-99.59 Miscellaneous Exhibit -- exhibit99-59 HTML 37K 7: EX-99.6 Miscellaneous Exhibit -- exhibit99-6 HTML 499K 61: EX-99.60 Miscellaneous Exhibit -- exhibit99-60 HTML 34K 62: EX-99.61 Miscellaneous Exhibit -- exhibit99-61 HTML 31K 63: EX-99.62 Miscellaneous Exhibit -- exhibit99-62 HTML 33K 64: EX-99.63 Miscellaneous Exhibit -- exhibit99-63 HTML 35K 65: EX-99.64 Miscellaneous Exhibit -- exhibit99-64 HTML 33K 66: EX-99.65 Miscellaneous Exhibit -- exhibit99-65 HTML 36K 67: EX-99.66 Miscellaneous Exhibit -- exhibit99-66 HTML 37K 68: EX-99.67 Miscellaneous Exhibit -- exhibit99-67 HTML 37K 69: EX-99.68 Miscellaneous Exhibit -- exhibit99-68 HTML 31K 70: EX-99.69 Miscellaneous Exhibit -- exhibit99-69 HTML 37K 8: EX-99.7 Miscellaneous Exhibit -- exhibit99-7 HTML 155K 71: EX-99.70 Miscellaneous Exhibit -- exhibit99-70 HTML 33K 72: EX-99.71 Miscellaneous Exhibit -- exhibit99-71 HTML 30K 73: EX-99.72 Miscellaneous Exhibit -- exhibit99-72 HTML 32K 74: EX-99.73 Miscellaneous Exhibit -- exhibit99-73 HTML 177K 75: EX-99.74 Miscellaneous Exhibit -- exhibit99-74 HTML 37K 76: EX-99.75 Miscellaneous Exhibit -- exhibit99-75 HTML 35K 77: EX-99.76 Miscellaneous Exhibit -- exhibit99-76 HTML 159K 78: EX-99.77 Miscellaneous Exhibit -- exhibit99-77 HTML 160K 79: EX-99.78 Miscellaneous Exhibit -- exhibit99-78 HTML 42K 80: EX-99.79 Miscellaneous Exhibit -- exhibit99-79 HTML 35K 9: EX-99.8 Miscellaneous Exhibit -- exhibit99-8 HTML 75K 81: EX-99.80 Miscellaneous Exhibit -- exhibit99-80 HTML 35K 82: EX-99.81 Miscellaneous Exhibit -- exhibit99-81 HTML 588K 83: EX-99.82 Miscellaneous Exhibit -- exhibit99-82 HTML 46K 84: EX-99.83 Miscellaneous Exhibit -- exhibit99-83 HTML 50K 85: EX-99.84 Miscellaneous Exhibit -- exhibit99-84 HTML 47K 86: EX-99.85 Miscellaneous Exhibit -- exhibit99-85 HTML 35K 87: EX-99.86 Miscellaneous Exhibit -- exhibit99-86 HTML 355K 88: EX-99.87 Miscellaneous Exhibit -- exhibit99-87 HTML 130K 89: EX-99.88 Miscellaneous Exhibit -- exhibit99-88 HTML 33K 90: EX-99.89 Miscellaneous Exhibit -- exhibit99-89 HTML 33K 10: EX-99.9 Miscellaneous Exhibit -- exhibit99-9 HTML 32K 91: EX-99.90 Miscellaneous Exhibit -- exhibit99-90 HTML 37K 92: EX-99.91 Miscellaneous Exhibit -- exhibit99-91 HTML 35K 93: EX-99.92 Miscellaneous Exhibit -- exhibit99-92 HTML 39K 94: EX-99.93 Miscellaneous Exhibit -- exhibit99-93 HTML 35K 95: EX-99.94 Miscellaneous Exhibit -- exhibit99-94 HTML 59K 96: EX-99.95 Miscellaneous Exhibit -- exhibit99-95 HTML 35K 97: EX-99.96 Miscellaneous Exhibit -- exhibit99-96 HTML 42K 98: EX-99.97 Miscellaneous Exhibit -- exhibit99-97 HTML 31K 99: EX-99.98 Miscellaneous Exhibit -- exhibit99-98 HTML 39K 100: EX-99.99 Miscellaneous Exhibit -- exhibit99-99 HTML 48K
Cannex Capital Holdings Inc. - Exhibit 99.113 - Filed by newsfilecorp.com |
CANNEX SECURITYHOLDERS FORMALLY APPROVE 4FRONT
AGREEMENT,
CSE GRANTS CONDITIONAL APPROVAL,
TRADING TO RESUME, AND UPDATE
ON THE CLOSING OF
THE BUSINESS COMBINATION WITH 4FRONT
Closing of the Business Combination will require consent from
U.S. federal antitrust regulators,
final court approval of the Plan of
Arrangement, and final approval by the CSE
Vancouver, BC, April 26, 2019 – Cannex Capital Holdings Inc. (CSE: CNNX)(OTCQX: CNXXF) (“Cannex” or the “Company”) is pleased to announce that securityholders of Cannex have voted overwhelmingly in favour of the business combination (the “Transaction”) with 4Front Holdings, LLC (“4Front”) at a special meeting of securityholders (the “Meeting”) of Cannex held on April 18, 2019. Additional information on the Transaction can be found in the management information circular of Cannex dated March 19, 2019, which is available under Cannex’s SEDAR profile at www.sedar.com.
The Transaction, whereby the former securityholders of Cannex and 4Front will become securityholders in the combined company (the “Resulting Issuer”), was approved by 99.97% of holders of common shares of Cannex, 100% of holders of Class A convertible restricted voting shares of Cannex and 100% of the holders of senior convertible notes of Cannex who voted at the Meeting. Cannex will post the voting results under its SEDAR profile.
“We have cleared significant hurdles associated with our business combination with 4Front. Even though the voting agreements had us confident in the outcome of the shareholder vote, 99.97% is a great confirmation on the merits of our merger and its terms for Cannex shareholders,” said Anthony Dutton, CEO of Cannex.
CSE Grants Conditional Approval and to Lift Halt on Stock
The Company is also pleased to announce that the Canadian Securities Exchange (the “CSE”) has conditionally approved the resulting issuer for listing, and will lift the trading halt on April 29th, 2019. Trading will continue as Cannex until the transaction has been completed, at which time the CSE will issue a bulletin announcing the listing of 4Front Ventures Corp.
Update on Business Combination with 4Front
Pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”), as amended, Cannex and 4Front were required to file a pre-Transaction notification to federal antitrust authorities and must observe a waiting period before completing the Transaction. As part of the HSR Act review process, Cannex and 4Front received a request for additional information (the "Second Request") from the US Department of Justice Antitrust Division on April 18, 2019. The Second Request extends the HSR Act waiting period for up to 30 days after Cannex and 4Front have each substantially complied with the Second Request.
Cannex and 4Front are working to substantially comply with the Second Request as quickly as feasible. Based on other recent business combinations within the cannabis space, numerous larger competitors of the combined companies in North America, and limited geographic and business overlap of the companies, both Cannex and 4Front believe that the Transaction does not raise substantial competitive concerns, and that it will enhance competition in nascent markets.
“4Front’s confidence in the benefits of partnering with Cannex have only grown, which is not always the case when navigating months of detailed administrative work and the corresponding issues that surface,” said Josh Rosen, CEO of 4Front.
Cannex Capital | www.cannexcapital.com | info@cannexcapital.com | 604 628 9338 |
Closing of the Transaction remains subject to resolving the Second Request, final regulatory approval, and other customary completion conditions. Upon receipt of such regulatory approval and satisfaction or waiver of all other completion conditions, Cannex and 4Front will make an application to the Supreme Court of British Columbia for the final order in respect of the Transaction. A news release will follow when a hearing of the application for the final order in respect of the Transaction has been scheduled.
About Cannex Capital Holdings Inc.
Cannex, through its wholly-owned subsidiaries, provides a wide range of services including real estate, management, financial, branding and IP to licensed cannabis business operators domestically and internationally. Cannex is focused on premium indoor cultivation, extraction, manufacturing and branding of edible and derivative products as well as retail operations. Cannex is undertaking expansion initiatives to support the acquisition and development of additional assets in legal medical and recreational cannabis markets. Based in Vancouver, BC, Cannex is managed by a team of experienced industry and capital markets experts who are committed to aggressive, cost-effective growth. Cannex currently owns BrightLeaf Development LLC which holds real estate assets, property leases, brands and intellectual property, and material supply agreements with Superior Gardens LLC (d/b/a Northwest Cannabis Solutions), Washington State’s and the Pacific Northwest’s largest full-line cannabis producer/processor, as well as 7Point Holdings LLC, another Washington State licensed cannabis producer/processor. Northwest Cannabis Solutions and 7Point Holdings are not Cannex subsidiaries, and Cannex does not hold any ownership position in either company.
About 4Front Holdings, LLC
4Front is building a next-generation company in the cannabis industry, based upon strategic and aligned leadership, battle-tested operating capabilities, transparent and principled governance, and a commitment to developing and supporting people and communities. Led by a group of professionals with experience in finance, real estate, manufacturing, distribution & logistics, multi-location retail & hospitality operations and talent development & retention, 4Front has invested heavily to assemble a comprehensive collection of management skills and hands-on operating expertise that can support the rapid operational growth opportunity being afforded by the increased legalization of cannabis across the globe. For more information, visit 4Front’s website. (www.4frontventures.com).
Cannex Capital Holdings Inc. |
Anthony Dutton, CEO |
(604) 649-7787 |
Email: adutton@cannexcapital.com |
Website: www.cannexcapital.com |
Media Contact for 4Front Holdings, LLC |
Anne Donohoe / Nick Opich |
KCSA Strategic Communications |
adonohoe@kcsa.com / nopich@kcsa.com |
212-896-1265 / 212-896-1206 |
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
2
This news release was prepared by management of Cannex, which takes full responsibility for its contents. The CSE has not reviewed and does not accept responsibility for the adequacy of this news release.
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Cannex’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements. These forward-looking statements include statements regarding the anticipated closing date of the lifting of the trading halt by the CSE, the ability of Cannex and 4Front to satisfy any competitive concerns raised in the HSR process, the ability of Cannex and 4Front to comply with the Second Request and obtain regulatory approval and satisfy or waive all closing conditions to the Transaction.
There can be no assurance that such forward-looking statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking statements. These forward-looking statements reflect the current beliefs of Cannex and are based on information currently available to Cannex and on assumptions that Cannex believes are reasonable. These assumptions include, but are not limited to, the anticipated closing date of the lifting of the trading halt by the CSE and the ability of Cannex and 4Front to obtain regulatory approval and satisfy or waive all closing conditions to the Transaction. Forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Resulting Issuer to be materially different from those expressed or implied by such forward-looking statements. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive regulatory approvals; failure to fulfill or waive any of the conditions precedent to the definitive agreement relating to the Transaction or failure to perform all the necessary steps with respect to the Transaction; the actual results of future operations compared to the forecasted results contained in the forward-looking statements; competition; changes in legislation affecting the Resulting Issuer; the timing and availability of external financing on acceptable terms; and other risk factors.
Cannex cautions that the foregoing list of material factors is not exhaustive. When relying on Cannex’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Cannex has assumed that the material factors referred to in the previous paragraph will not cause such forward- looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking information contained in this news release represents Cannex’s expectations as of the date of this news release and, accordingly, are subject to change after such date.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Cannex disclaims any intention or obligation to update or revise such information, except as required by applicable law.
3
This ‘40FR12G’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 7/16/19 | None on these Dates | ||
4/26/19 | ||||
4/18/19 | ||||
3/19/19 | ||||
List all Filings |